One Health Biosensing

News

One Drop founder Jeff Dachis brought his new product out of stealth mode at Frontiers Health -- a CGM for use beyond Type 1 diabetes.

News

Shares in uniQure have rocketed this morning, as it emerges that the FDA will not require it to run a new trial of Huntington's gene therapy AMT-130.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.